{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:02Z","timestamp":1760188502014},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf01709666","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T01:15:10Z","timestamp":1118538910000},"page":"45-47","source":"Crossref","is-referenced-by-count":16,"title":["Myelodysplastic syndrome associated with relapsing polychondritis: Unusual transformation from refractory anemia to chronic myelomonocytic leukemia"],"prefix":"10.1007","volume":"67","author":[{"given":"T.","family":"Shirota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tonozuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01709666_CR1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2133.1991.tb14801.x","volume":"125","author":"A Anstey","year":"1991","unstructured":"Anstey A, Mayou S, Morgan K, et al. (1991) Relapsing polychondritis: autoimmunity to type-II collagen and treatment with cyclosporin A. Br J Dermatol 125: 588\u2013591","journal-title":"Br J Dermatol"},{"key":"BF01709666_CR2","first-page":"157","volume":"18","author":"P Arlet","year":"1989","unstructured":"Arlet P, Pris J, Sallerin E, et al. (1989) Polychondrite chronique atrophiante. Presse Med 18: 157\u2013160","journal-title":"Presse Med"},{"key":"BF01709666_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. (1982) Proposais for the classification of the myelodysplastic syndromes. Br J Hematol 51: 189\u2013199","journal-title":"Br J Hematol"},{"key":"BF01709666_CR4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ajh.2830400110","volume":"40","author":"KV Besien","year":"1992","unstructured":"Besien KV, Tricot G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 40: 47\u201350","journal-title":"Am J Hematol"},{"key":"BF01709666_CR5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.1983.tb02071.x","volume":"54","author":"AG Bynoe","year":"1983","unstructured":"Bynoe AG, Scott CS, Ford P, et al. (1983) Decreased T-helper cells in the myelodysplastic syndromes. Br J Hematol 54: 97\u2013102","journal-title":"Br J Hematol"},{"key":"BF01709666_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/ard.40.5.473","volume":"40","author":"R Ebringer","year":"1981","unstructured":"Ebringer R, Rook G, Swana GT, et al. (1981) Autoantibodies to cartilage and type-II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 40: 473\u2013479","journal-title":"Ann Rheum Dis"},{"key":"BF01709666_CR7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1136\/jcp.38.8.908","volume":"38","author":"T Economopoulos","year":"1985","unstructured":"Economopoulos T, Economidou J, Giannopoulos G, et al. (1985) Immune abnormalities in myelodysplastic syndromes. J Clin Pathol 38: 908\u2013911","journal-title":"J Clin Pathol"},{"key":"BF01709666_CR8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJM197811302992202","volume":"299","author":"JM Foidart","year":"1978","unstructured":"Foidart JM, Abe S, Martin GR, et al. (1978) Antibodies to type-II collagen in relapsing polychondritis. N Engl J Med 299: 1203\u20131207","journal-title":"N Engl J Med"},{"key":"BF01709666_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO;2-Q","volume":"56","author":"K Foucar","year":"1985","unstructured":"Foucar K, Langdon RM, Armitage JO, et al. (1985) Myelodysplastic syndrome. A clinical and pathologic analysis of 109 cases. Cancer 56: 553\u2013561","journal-title":"Cancer"},{"key":"BF01709666_CR10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0049-0172(83)90005-7","volume":"13","author":"L Giroux","year":"1983","unstructured":"Giroux L, Paquin F, Guerard-Desjardins MJ, et al. (1983) Relapsing polychondritis: an autoimmune disease. Semin Arthritis Rheum 13: 182\u2013187","journal-title":"Semin Arthritis Rheum"},{"key":"BF01709666_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0145-2126(84)90147-4","volume":"8","author":"G Kerndrup","year":"1984","unstructured":"Kerndrup G, Meyer K, Ellegaard J, et al. (1984) Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leukemia Res 8: 239\u2013247","journal-title":"Leukemia Res"},{"key":"BF01709666_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","volume":"55","author":"LP McAdam","year":"1976","unstructured":"McAdam LP, O'Hanlan MA, Bluestone R, et al. (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55: 193\u2013215","journal-title":"Medicine"},{"key":"BF01709666_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.1780250304","volume":"25","author":"JW McCune","year":"1982","unstructured":"McCune JW, Scheller AL, Dynesius-Trentham RA, et al. (1982) Type-II collagen-induced auricular arthritis. Arthritis Rheum 25: 266\u2013273","journal-title":"Arthritis Rheum"},{"key":"BF01709666_CR14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7326\/0003-4819-104-1-74","volume":"104","author":"CJ Michet","year":"1986","unstructured":"Michet CJ, McKenna CH, Luthra HS, et al. (1986) Relapsing polychondritis: survival and predictive role of early disease manifestations. Ann Intern Med 104: 74\u201378","journal-title":"Ann Intern Med"},{"key":"BF01709666_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2141.1986.tb07504.x","volume":"63","author":"GJ Mufti","year":"1986","unstructured":"Mufti GJ, Figes A, Hamblin TJ, et al. (1986) Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 63: 143\u2013147","journal-title":"Br J Haematol"},{"key":"BF01709666_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/rheumatology\/25.1.85","volume":"25","author":"L Nashef","year":"1986","unstructured":"Nashef L, Doherty M, Dieppe P (1986) Relapsing polychondritis: a primary or secondary autoimmune disease? Br J Rheum 25: 85\u201386","journal-title":"Br J Rheum"},{"key":"BF01709666_CR17","first-page":"800","volume":"52","author":"M Omine","year":"1989","unstructured":"Omine M, Yamaguchi H (1989) Clinical aspects of the myelodysplastic syndrome (MDS) with special reference to refractory anemia with excess of blasts (RAEB). Acta Haematol Jpn 52: 800\u2013810","journal-title":"Acta Haematol Jpn"},{"key":"BF01709666_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0145-2126(92)90105-G","volume":"16","author":"GF Sanz","year":"1992","unstructured":"Sanz GF, Sanz MA (1992) Prognostic factors in myelodysplastic syndromes. Leuk Res 16: 77\u201386","journal-title":"Leuk Res"},{"key":"BF01709666_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2141.1985.tb04063.x","volume":"61","author":"M Vallespi","year":"1985","unstructured":"Vallespi M, Torrabadella M, Julia A, et al. (1985) Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol 61: 83\u201392","journal-title":"Br J Haematol"},{"key":"BF01709666_CR20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0609.1988.tb00880.x","volume":"41","author":"M Weide van der","year":"1988","unstructured":"Weide M van der, Sizoo W, Nauta JJP, et al. (1988) Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients. Eur J Haematol 41: 115\u2013122","journal-title":"Eur J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709666.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01709666\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T16:20:39Z","timestamp":1706286039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01709666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF01709666"],"URL":"https:\/\/doi.org\/10.1007\/bf01709666","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}